Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why SQZ Biotechnologies Sank on Friday

TheMotleyFool

0 0

SQZ Biotechnologies (NYSE: SQZ) fell by nearly 16% on Friday following the company's announcement of a new funding round.

SQZ (pronounced "squeeze") is issuing 3 million new shares of common stock in an underwritten public offering that was priced Friday at $20 per share. This is below the company's $22 per share closing price on Thursday.

As is customary in secondary stock flotations, SQZ's underwriters have been granted a 30-day option to purchase extra stock. In this case, they can buy up to 450,000 shares.

Source Fool.com

Like: 0

SQZ

Share